Capital Management Corp Bristol Myers Squibb CO Transaction History

Capital Management Corp

$526 Million
Q2 2025

A detailed history of Capital Management Corp transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Capital Management Corp holds 101,855 shares of BMY stock, worth $4.68 Million. This represents 0.9% of its overall portfolio holdings.

Number of Shares

101,855

Previous 225,844 54.9%

Holding current value

$4.68 Million

Previous $13.8 Million 65.78%

% of portfolio

0.9%

Previous 2.78%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 28, 2025	SELL	$44.12 - $59.6 $5.47 Million - $7.39 Million	-123,989 Reduced 54.9%	101,855 $4.71 Million
Q1 2025 May 05, 2025	SELL	$53.9 - $63.11 $572,687 - $670,543	-10,625 Reduced 4.49%	225,844 $13.8 Million
Q4 2024 Feb 07, 2025	SELL	$51.92 - $59.94 $99,167 - $114,485	-1,910 Reduced 0.8%	236,469 $13.4 Million
Q3 2024 Oct 30, 2024	BUY	$39.66 - $51.75 $1.23 Million - $1.61 Million	31,103 Added 15.01%	238,379 $12.3 Million
Q2 2024 Jul 25, 2024	BUY	$40.25 - $52.99 $666,741 - $877,779	16,565 Added 8.69%	207,276 $8.61 Million
Q1 2024 May 10, 2024	BUY	$47.98 - $54.4 $366,231 - $415,235	7,633 Added 4.17%	190,711 $10.3 Million
Q4 2023 Feb 01, 2024	SELL	$48.48 - $57.85 $1.58 Million - $1.88 Million	-32,528 Reduced 15.09%	183,078 $9.39 Million
Q3 2023 Oct 30, 2023	SELL	$57.89 - $64.73 $113,001 - $126,352	-1,952 Reduced 0.9%	215,606 $12.5 Million
Q2 2023 Jul 27, 2023	BUY	$63.71 - $70.74 $1.48 Million - $1.64 Million	23,159 Added 11.91%	217,558 $13.9 Million
Q1 2023 May 08, 2023	BUY	$65.71 - $74.53 $2.38 Million - $2.7 Million	36,202 Added 22.88%	194,399 $13.5 Million
Q4 2022 Jan 24, 2023	SELL	$68.48 - $81.09 $363,971 - $430,993	-5,315 Reduced 3.25%	158,197 $0
Q3 2022 Oct 31, 2022	SELL	$0.13 - $76.84 $447 - $264,560	-3,443 Reduced 2.06%	163,512 $11.6 Million
Q2 2022 Jul 25, 2022	SELL	$72.62 - $79.98 $1.8 Million - $1.98 Million	-24,752 Reduced 12.91%	166,955 $12.9 Million
Q1 2022 May 03, 2022	SELL	$61.48 - $73.72 $1.44 Million - $1.72 Million	-23,364 Reduced 10.86%	191,707 $14 Million
Q4 2021 Feb 08, 2022	SELL	$53.63 - $62.52 $1.53 Million - $1.79 Million	-28,554 Reduced 11.72%	215,071 $13.4 Million
Q3 2021 Oct 25, 2021	SELL	$59.17 - $69.31 $1.35 Million - $1.58 Million	-22,732 Reduced 8.53%	243,625 $14.4 Million
Q2 2021 Jul 30, 2021	SELL	$61.91 - $67.42 $755,054 - $822,254	-12,196 Reduced 4.38%	266,357 $17.8 Million
Q1 2021 Apr 26, 2021	BUY	$59.34 - $66.74 $4.37 Million - $4.92 Million	73,665 Added 35.95%	278,553 $17.6 Million
Q4 2020 Feb 04, 2021	BUY	$57.74 - $65.43 $27,599 - $31,275	478 Added 0.23%	204,888 $12.7 Million
Q3 2020 Oct 27, 2020	BUY	$57.43 - $63.64 $199,741 - $221,339	3,478 Added 1.73%	204,410 $12.3 Million
Q2 2020 Jul 29, 2020	BUY	$54.82 - $64.09 $1.51 Million - $1.77 Million	27,612 Added 15.93%	200,932 $11.8 Million
Q1 2020 May 05, 2020	BUY	$46.4 - $67.43 $8.04 Million - $11.7 Million	173,320 New	173,320 $9.66 Million
Q1 2019 Apr 25, 2019	SELL	$45.12 - $53.8 $9.1 Million - $10.8 Million	-201,655 Closed	0 $0
Q4 2018 Jan 29, 2019	BUY	$48.76 - $63.23 $413,533 - $536,253	8,481 Added 4.39%	201,655 $10.5 Million
Q3 2018 Oct 31, 2018	BUY	$55.19 - $62.25 $375,567 - $423,611	6,805 Added 3.65%	193,174 $12 Million
Q2 2018 Jul 27, 2018	BUY	$50.53 - $62.98 $7.54 Million - $9.4 Million	149,187 Added 401.23%	186,369 $10.3 Million
Q1 2018 Apr 25, 2018	BUY	$59.92 - $68.98 $2.23 Million - $2.56 Million	37,182 New	37,182 $2.35 Million

Others Institutions Holding BMY

# of Institutions

2,668

Shares Held

1.58B

Call Options Held

26.1M

Put Options Held

23.8M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $97.7B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Management Corp , based on Form 13F filings with the SEC.

News

Stay updated on Capital Management Corp with notifications on news.

Account

Capital Management Corp Bristol Myers Squibb CO Transaction History